The Akt/NF-κB pathways could be involved in the expression of these molecules in HTNV-infected HUVECs; therefore, cardamonin could be a potential beneficial agent for HFRS therapy. The gene discussed is AKT1; the disease is hemorrhagic fever with renal syndrome.